US20040220659A1 - Stent covering formed of porous polytetraflouroethylene - Google Patents

Stent covering formed of porous polytetraflouroethylene Download PDF

Info

Publication number
US20040220659A1
US20040220659A1 US10/858,589 US85858904A US2004220659A1 US 20040220659 A1 US20040220659 A1 US 20040220659A1 US 85858904 A US85858904 A US 85858904A US 2004220659 A1 US2004220659 A1 US 2004220659A1
Authority
US
United States
Prior art keywords
stent
siloxane
porous
cover
ptfe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/858,589
Inventor
Timothy Girton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Priority to US10/858,589 priority Critical patent/US20040220659A1/en
Publication of US20040220659A1 publication Critical patent/US20040220659A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCIMED LIFE SYSTEMS, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/048Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146Porous materials, e.g. foams or sponges
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C67/00Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
    • B29C67/20Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 for porous or cellular articles, e.g. of foam plastics, coarse-pored
    • B29C67/202Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 for porous or cellular articles, e.g. of foam plastics, coarse-pored comprising elimination of a solid or a liquid ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0066Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable

Definitions

  • the present invention relates to an endoprosthesis device or intraluminal device, in particular a stent, having a covering comprising porous polytetrafluoroethylene formed by removing the siloxane from an interpenetrating network of polytetrafluoroethylene and siloxane, and to a method of making the endoprosthesis device.
  • the stent covering can be applied on the exterior surface of the stent, on the interior surface of the stent, or both, at a thickness of as low as about 15 microns.
  • Endoprosthesis devices including stents, stent-grafts, grafts, vena cava filters, balloon catheters, and so forth, are placed or implanted within various body vessels for the treatment of various diseases.
  • One particular type of an endoprosthesis device is the stent.
  • a stent is implanted within a vessel for the treatment of stenoses, strictures, or aneurysms in the blood vessels.
  • the devices are implanted within the vascular system to reinforce diseased, partially occluded, weakened or abnormally dilated sections of the blood vessel.
  • Stents are often employed after angioplasty to prevent restenosis of a diseased blood vessel. While stents are most notably used in blood vessels, they have also been implanted in other bodily vessels including urinary tracts and bile ducts to reinforce and prevent neoplastic growth.
  • Stents are typically longitudinal tubular devices formed of biocompatible materials and come in a variety of construction types, and are often expandable in nature. Many if not all of the materials used for stents involve metal or carbon fiber materials which are highly electro-positive and are bio-active. Since stents tend to be used under conditions were they are counteracting disease processes, supporting healing processes, or guarding against stenosis of a passage, bio-activity, which may encourage undesirable or poorly regulated growth processes, or lead to clot formation, should be avoided.
  • Coating of the stent can keep the stent from directly contacting surrounding tissue or fluids, and thus can theoretically protect against unwanted electrochemically induced tissue reactions.
  • One approach to this drawback is to provide a coating, liner, cover or both, for the stent which prevents the healing or diseased layer of tissue from directly contacting the stent, or from passing through the stent in any way.
  • Such liners may be formed, for example, of porous polytetrafluoroethylene (PTFE) which allows the passage of fluids and vital materials while serving as a barrier to tissue growth.
  • PTFE porous polytetrafluoroethylene
  • a further difficulty which may arise is that the layer or sleeve of polymer must be attached to the stent for example, by staples or sutures at one end, or is prone to developing loose pockets or folds which might accumulate organic matter or lead to sepsis or unusual growth.
  • the necessarily thin liner material may detach or degrade.
  • the risk of loose or unattached liner material is particularly great for constructions which utilize poorly adherent polymers, such as PTFE, or structures which seek to combine an expandable stent of stiff material, which changes both its dimension and its shape, with a dissimilar liner or shell.
  • a metallic expandable stent includes an outer covering of ePTFE.
  • the ePTFE cover exhibits suitable expansion capabilities so as to enable the cover to expand upon expansion of the underlying stent.
  • a polytetrafluoroethylene/lubricant blend may be extruded into a tube and the tube heated to remove the lubricant.
  • the ePTFE in order to impart the expandable characteristics to the ePTFE cover during formation of the ePTFE cover material, the ePTFE must undergo successive processing steps of expanding the material, sintering the material, radially dilating the material and resintering the dilated material, a procedure that is quite process intensive.
  • the device described therefore requires precise manufacturing techniques and is extremely processing sensitive. Careful processing of the material forming the cover is required in order for the cover to exhibit sufficient expansion capabilities.
  • U.S. Pat. No. 5,824,046 describes a composite intraluminal device, in particular an elongate radially expandable tubular stent having an interior luminal surface and an opposed exterior surface extending along a longitudinal stent axis.
  • a stent cover is formed of unsintered ePTFE which is expandable.
  • the present invention relates to a method of forming porous polytetrafluoroethylene (PTFE) without having to stretch or expand the material, and to a radially expandable endoprosthesis device covered with the solid but expandable polymer covering comprising the porous PTFE material obtained using the method of the present invention.
  • the porous PTFE covering physically isolates the endoprosthesis from surrounding blood and tissue.
  • the porous PTFE is prepared by extracting siloxane from an interpenetrating network (IPN) of PTFE and siloxane, leaving behind a porous PTFE structure without having to expand and stretch the PTFE. Consequently, the PTFE material used in the endoprosthesis device coverings of the present invention is not expanded PTFE, but it is porous.
  • IPN interpenetrating network
  • the end of the prosthesis device of the present invention includes an elongate radially expandable tubular stent having an interior surface and in exterior surface extending along a longitudinal stent access.
  • the expandable tubular stent has a stent cover on said interior surface, exterior surface or both, the cover being formed of a porous polytetrafluoroethylene.
  • the porous polytetraflouroethylene cover is a non-stretched porous structure, the non-stretched structure lacking note and viable structure.
  • the present invention relates to a radially expandable stent for use in treating stenoses wherein the stent is covered with an expandable polymer covering comprising the porous PTFE prepared according to the present invention that physically isolates the stent from surrounding blood and tissue.
  • FIG. 1 is a perspective view of one type of intraluminal device that may be used in the present invention.
  • FIG. 2 is a perspective view of a different intraluminal device which may be used in the present invention.
  • FIG. 3 is a perspective view of the intraluminal device of FIG. 1 illustrating the device having a polytetrafluoroethylene cover on both the inner and outer surface of the device.
  • FIG. 4 is a cross-sectional view of the same intraluminal device shown in FIG. 3.
  • FIG. 5 is the same intraluminal device as in FIG. 3 illustrating only the outer surface cover.
  • FIG. 6 is the same intraluminal device as in FIG. 3 with the exception that only a liner or inner surface cover is shown.
  • FIG. 7 is a cross-section of the porous PTFE material of the present invention.
  • FIG. 8 is a schematic representation of ePTFE prior art.
  • the present invention provides a covered stent which may be implanted intraluminally within a body vessel and disposed adjacent an occluded, weakened or otherwise damaged portion of the vessel so as to hold the vessel open.
  • the covered stent is typically delivered intraluminally via a balloon catheter.
  • the device is delivered in a compressed condition and once properly positioned may be deployed by radial expansion.
  • the most common form of deploying the intraluminal device is by balloon expansion, however, the present invention may also be deployed by use of a self-expanding stent.
  • FIG. 1 illustrates an intraluminal device in the form of a stent 12 .
  • FIG. 2 illustrates an intraluminal device in the form of a stent 5 having a different construction than that shown in FIG. 1.
  • FIG. 3 illustrates generally at 10 an intraluminal device in the form of a stent 12 as shown in FIG. 1 having a cover 14 on the outer surface 12 and liner 16 on the inner surface, both of which may be of the porous structure shown below in FIG. 7.
  • the stent may optionally have only a cover 14 as shown in FIG. 5, or only a liner 16 as shown in FIG. 6, or both as shown in FIG. 3.
  • the stent has both a cover 14 and a liner 16 .
  • the liner, cover, or both, will be referred to hereinafter collectively as a cover or covering.
  • the cover provides an effective barrier about the stent 12 preventing excessive cell or tissue ingrowth or thrombus formation through the expanded wall of the stent 12 .
  • FIG. 4 is a cross-sectional view of the same device as shown in FIG. 3 with a cover 14 and a liner 16 around stent 12 .
  • FIG. 1 is a more detailed illustration of stent 10 and shows generally an elongate tube.
  • the body of stent 12 defines an opposed interior surface 11 and an exterior surface 13 and is formed of a generally open configuration having a plurality of openings or passages provided for longitudinal flexibility of the stent as well as permitting the stent to be radially expanded once deployed in the body lumen.
  • Both the interior surface 11 and the exterior surface 13 may have the porous PTFE covering of the present invention.
  • the covering On the interior surface the covering is referred to as the liner 12 as shown in FIG. 1 and on the exterior surface it is referred to as a cover 14 as shown in FIG. 1.
  • Stent 12 may be employed in combination with a cover 14 or liner 16 but is preferably employed with both.
  • the cover 14 may be applied over the tubular stent 12 so as to fully circumferentially surround the stent 12
  • the liner 16 is applied inside and through the stent 12 so that the stent 12 fully circumferentially surrounds the liner 16 .
  • the porous polytetrafluoroethylene (PTFE) material useful herein is first obtained in the form of an interpenetrating network of PTFE and siloxane, in particular, polydimethylsiloxane.
  • the silicone is then extracted from the IPN using either thermal or chemical means. The removal of the silicone leaves behind a porous PTFE structure.
  • a particular material for use herein is Silon®, an interpenetrating polymer network (IPN) of polytetrafluoroethylene (PTFE) and polydimethylsiloxane (silicone) supplied by Bio Med Sciences, Inc. located in Bethlehem, PA.
  • IPN interpenetrating polymer network
  • PTFE polytetrafluoroethylene
  • silicone polydimethylsiloxane
  • FIG. 7 illustrates generally at 20 a porous PTFE structure after removal of the siloxane.
  • the removal of the siloxane leaves behind the porous structure wherein voids or pockets of air 25 , are found intermeshed in between pockets of PTFE 30 .
  • the novel porous PTFE structure produced by the present inventive process is quite different from the porous structure produced by PTFE which has been stretched, or expanded.
  • PTFE which has been stretched, or ePTFE has a node and fibril structure as seen in FIG. 8. After stretching, the ePTFE possesses nodes 32 connected to fibrils 34 . In between the nodes and fibrils are pores 36 .
  • Removing the siloxane from the IPN of siloxane/PTFE through the use of heat involves heating the IPN structure to temperatures of between about 300° C. and about 390° C.
  • Chemical removal of the siloxane may be accomplished using a compound selected from the group consisting of toluene, heptane, chloroform.
  • Sintering is typically accomplished at or above the crystalline melting point of PTFE. Sintering is synonymous with recrystallization. It refers to the bonding of particles in a mass by molecular (or atomic) attraction in the solid state through the application of heat below the melting point of the polymer. Sintering causes the strengthening of the powder mass and normally results in densification and often recrystallization.
  • a PTFE tube may be extruded as a tube from an extrusion device, or extruded as a film and subsequently wrapped into a tube. Extrusion techniques of PTFE are well known in the art.
  • the stent may be covered on the interior surface 11 of the stent 10 , the exterior surface 13 of the stent 10 , or both.
  • the stent 10 is covered on both the interior 11 and the exterior 13 surfaces of the stent 10 . Having the entire surface of the stent 10 covered with the porous PTFE of the present invention provides an effective barrier about the stent 10 preventing excessive cell or tissue growth, or thrombus formation through the expanded wall of a tubular stent 10 .
  • the material In order for the covering of porous PTFE to function effectively in combination with an expandable stent, the material must exhibit sufficient expansion characteristics so as to enable the stent cover to expand along with the radial expansion of the stent 10 . If the covering material does not effectively expand with the stent, several problems can arise. The covering material may tear, and may even detach from the surface of the stent if improper or dissimilar expansion of the covering material occurs with the expansion of the stent.
  • the PTFE may be fused or welded around or to the metal stent. This may be accomplished either through a heating process and/or bonding process. If heating is utilized, typically the PTFE will be heated above its sintering temperature.
  • an adhesive preferably a biocompatible adhesive is used.
  • adhesives are known to one of skill in the art and include, for example, polyurethanes, epoxies, cyanoacrylates, polyamides, polyimides, silicones, and so forth. Dispersions of PTFE or FEP (fluoroethylpropylene) may also be utilized. This list is not exclusive and is intended for illustrative purposes only, and is in no way intended as a limitation on the scope of the present invention. There is a vast number of adhesives that can be used for such applications, limited by their biocompatibility, and by their ability to bond to polymeric materials (e.g. PTFE) and metals, particularly in aqueous environments.
  • polymeric materials e.g. PTFE
  • metals particularly in aqueous environments.
  • the covering material may also be assembled to the intraluminal device in more than one piece. Such a combination would require overlapping of sorts of the PTFE material, and subsequent fusion or adhesive bonding of the porous PTFE material to itself.
  • porous PTFE covering in a continuous form such as a membrane or thin film.
  • the porous PTFE (after removal of the siloxane), in the form of a membrane or a thin film, thus, preferably completely wraps the metal stent, thereby providing a barrier that physically isolates the stent from surrounding blood and tissue. This barrier further helps prevent healing or diseased layers of tissue from directly contacting the stent, or from passing through the stent in any way.
  • the porous PTFE allows the passage of fluids and vital materials, however, while still serving as a barrier to tissue growth.

Abstract

An endoprosthesis device and method of making it are disclosed. More particularly, the endoprosthesis is a porous PTFE article used in conjunction with a stent.

Description

    FIELD OF THE INVENTION
  • The present invention relates to an endoprosthesis device or intraluminal device, in particular a stent, having a covering comprising porous polytetrafluoroethylene formed by removing the siloxane from an interpenetrating network of polytetrafluoroethylene and siloxane, and to a method of making the endoprosthesis device. The stent covering can be applied on the exterior surface of the stent, on the interior surface of the stent, or both, at a thickness of as low as about 15 microns. [0001]
  • BACKGROUND OF THE INVENTION
  • Endoprosthesis devices including stents, stent-grafts, grafts, vena cava filters, balloon catheters, and so forth, are placed or implanted within various body vessels for the treatment of various diseases. One particular type of an endoprosthesis device is the stent. A stent is implanted within a vessel for the treatment of stenoses, strictures, or aneurysms in the blood vessels. The devices are implanted within the vascular system to reinforce diseased, partially occluded, weakened or abnormally dilated sections of the blood vessel. Stents are often employed after angioplasty to prevent restenosis of a diseased blood vessel. While stents are most notably used in blood vessels, they have also been implanted in other bodily vessels including urinary tracts and bile ducts to reinforce and prevent neoplastic growth. [0002]
  • Stents are typically longitudinal tubular devices formed of biocompatible materials and come in a variety of construction types, and are often expandable in nature. Many if not all of the materials used for stents involve metal or carbon fiber materials which are highly electro-positive and are bio-active. Since stents tend to be used under conditions were they are counteracting disease processes, supporting healing processes, or guarding against stenosis of a passage, bio-activity, which may encourage undesirable or poorly regulated growth processes, or lead to clot formation, should be avoided. [0003]
  • Coating of the stent can keep the stent from directly contacting surrounding tissue or fluids, and thus can theoretically protect against unwanted electrochemically induced tissue reactions. [0004]
  • In the field of expandable stents, a further problem arises due to the fact that many stent constructions involve structures that have numerous apertures or spaces between various strands or structural elements of the stent such as those structures that are filamentous, wire-like, or of a tubular nature in which various openings have been cut or etched into the stent. With these constructions, tissue may grow through the openings of the stent. Furthermore, the stent itself may provoke a foreign body reaction and be both a stimulus for and a framework supporting, proliferative tissue growth, resulting, for example, in scar tissue or restenosis of the very region it is placed to control. [0005]
  • One approach to this drawback is to provide a coating, liner, cover or both, for the stent which prevents the healing or diseased layer of tissue from directly contacting the stent, or from passing through the stent in any way. Such liners may be formed, for example, of porous polytetrafluoroethylene (PTFE) which allows the passage of fluids and vital materials while serving as a barrier to tissue growth. However, when applying such a construction, a further difficulty which may arise is that the layer or sleeve of polymer must be attached to the stent for example, by staples or sutures at one end, or is prone to developing loose pockets or folds which might accumulate organic matter or lead to sepsis or unusual growth. Also, the necessarily thin liner material may detach or degrade. The risk of loose or unattached liner material is particularly great for constructions which utilize poorly adherent polymers, such as PTFE, or structures which seek to combine an expandable stent of stiff material, which changes both its dimension and its shape, with a dissimilar liner or shell. [0006]
  • One method for overcoming these problems is found in U.S. Pat. No. 6,010,529 in which tube of polymeric material, e.g. expanded polytetrafluoroethylene (PTFE), is passed through the interior of a stent body and is turned back upon itself over the stent to form a cuff. The assembly is then heated and the outer layer contacts and coalesces with the inner layer, closely surrounding the stent body within a folded envelope having a continuous and seamless end. Porosity is imparted to the PTFE by previous stretching or expansion the material. [0007]
  • Another type of covered stent which permits radial expansion is shown in WO 96/00103. As shown and described therein, a metallic expandable stent includes an outer covering of ePTFE. The ePTFE cover exhibits suitable expansion capabilities so as to enable the cover to expand upon expansion of the underlying stent. A polytetrafluoroethylene/lubricant blend may be extruded into a tube and the tube heated to remove the lubricant. Then, in order to impart the expandable characteristics to the ePTFE cover during formation of the ePTFE cover material, the ePTFE must undergo successive processing steps of expanding the material, sintering the material, radially dilating the material and resintering the dilated material, a procedure that is quite process intensive. The device described therefore requires precise manufacturing techniques and is extremely processing sensitive. Careful processing of the material forming the cover is required in order for the cover to exhibit sufficient expansion capabilities. [0008]
  • U.S. Pat. No. 5,824,046 describes a composite intraluminal device, in particular an elongate radially expandable tubular stent having an interior luminal surface and an opposed exterior surface extending along a longitudinal stent axis. A stent cover is formed of unsintered ePTFE which is expandable. [0009]
  • There remains a need in the art to provide a stent with a cover material that is sufficiently expandable, has the requisite barrier properties and yet allows the passage of fluids and vital materials, without requiring extensive processing procedures and is thus easily manufactured and applied to the stent. [0010]
  • SUMMARY OF THE INVENTION
  • The present invention relates to a method of forming porous polytetrafluoroethylene (PTFE) without having to stretch or expand the material, and to a radially expandable endoprosthesis device covered with the solid but expandable polymer covering comprising the porous PTFE material obtained using the method of the present invention. The porous PTFE covering physically isolates the endoprosthesis from surrounding blood and tissue. [0011]
  • Specifically, the porous PTFE is prepared by extracting siloxane from an interpenetrating network (IPN) of PTFE and siloxane, leaving behind a porous PTFE structure without having to expand and stretch the PTFE. Consequently, the PTFE material used in the endoprosthesis device coverings of the present invention is not expanded PTFE, but it is porous. [0012]
  • In one embodiment the end of the prosthesis device of the present invention includes an elongate radially expandable tubular stent having an interior surface and in exterior surface extending along a longitudinal stent access. The expandable tubular stent has a stent cover on said interior surface, exterior surface or both, the cover being formed of a porous polytetrafluoroethylene. The porous polytetraflouroethylene cover is a non-stretched porous structure, the non-stretched structure lacking note and viable structure. [0013]
  • In particular, the present invention relates to a radially expandable stent for use in treating stenoses wherein the stent is covered with an expandable polymer covering comprising the porous PTFE prepared according to the present invention that physically isolates the stent from surrounding blood and tissue.[0014]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of one type of intraluminal device that may be used in the present invention. [0015]
  • FIG. 2 is a perspective view of a different intraluminal device which may be used in the present invention. [0016]
  • FIG. 3 is a perspective view of the intraluminal device of FIG. 1 illustrating the device having a polytetrafluoroethylene cover on both the inner and outer surface of the device. [0017]
  • FIG. 4 is a cross-sectional view of the same intraluminal device shown in FIG. 3. [0018]
  • FIG. 5 is the same intraluminal device as in FIG. 3 illustrating only the outer surface cover. [0019]
  • FIG. 6 is the same intraluminal device as in FIG. 3 with the exception that only a liner or inner surface cover is shown. [0020]
  • FIG. 7 is a cross-section of the porous PTFE material of the present invention. [0021]
  • FIG. 8 is a schematic representation of ePTFE prior art.[0022]
  • DETAILED DESCRIPTIONS OF THE PREFERRED EMBODIMENTS
  • The present invention provides a covered stent which may be implanted intraluminally within a body vessel and disposed adjacent an occluded, weakened or otherwise damaged portion of the vessel so as to hold the vessel open. The covered stent is typically delivered intraluminally via a balloon catheter. The device is delivered in a compressed condition and once properly positioned may be deployed by radial expansion. The most common form of deploying the intraluminal device is by balloon expansion, however, the present invention may also be deployed by use of a self-expanding stent. [0023]
  • FIG. 1 illustrates an intraluminal device in the form of a [0024] stent 12. FIG. 2 illustrates an intraluminal device in the form of a stent 5 having a different construction than that shown in FIG. 1.
  • FIG. 3 illustrates generally at [0025] 10 an intraluminal device in the form of a stent 12 as shown in FIG. 1 having a cover 14 on the outer surface 12 and liner 16 on the inner surface, both of which may be of the porous structure shown below in FIG. 7. The stent may optionally have only a cover 14 as shown in FIG. 5, or only a liner 16 as shown in FIG. 6, or both as shown in FIG. 3. In a preferred embodiment, the stent has both a cover 14 and a liner 16. The liner, cover, or both, will be referred to hereinafter collectively as a cover or covering. The cover provides an effective barrier about the stent 12 preventing excessive cell or tissue ingrowth or thrombus formation through the expanded wall of the stent 12.
  • FIG. 4 is a cross-sectional view of the same device as shown in FIG. 3 with a [0026] cover 14 and a liner 16 around stent 12.
  • FIG. 1 is a more detailed illustration of [0027] stent 10 and shows generally an elongate tube. The body of stent 12 defines an opposed interior surface 11 and an exterior surface 13 and is formed of a generally open configuration having a plurality of openings or passages provided for longitudinal flexibility of the stent as well as permitting the stent to be radially expanded once deployed in the body lumen. Both the interior surface 11 and the exterior surface 13 may have the porous PTFE covering of the present invention. On the interior surface the covering is referred to as the liner 12 as shown in FIG. 1 and on the exterior surface it is referred to as a cover 14 as shown in FIG. 1.
  • While the figures illustrate a particular construction of [0028] stent 10, one of skill in the art would recognize that the porous PTFE covering material as described by the present invention would find utility in any stent configuration, and in particular the open stent configurations.
  • [0029] Stent 12 may be employed in combination with a cover 14 or liner 16 but is preferably employed with both. The cover 14 may be applied over the tubular stent 12 so as to fully circumferentially surround the stent 12, while the liner 16 is applied inside and through the stent 12 so that the stent 12 fully circumferentially surrounds the liner 16.
  • The porous polytetrafluoroethylene (PTFE) material useful herein is first obtained in the form of an interpenetrating network of PTFE and siloxane, in particular, polydimethylsiloxane. The silicone is then extracted from the IPN using either thermal or chemical means. The removal of the silicone leaves behind a porous PTFE structure. A particular material for use herein is Silon®, an interpenetrating polymer network (IPN) of polytetrafluoroethylene (PTFE) and polydimethylsiloxane (silicone) supplied by Bio Med Sciences, Inc. located in Bethlehem, PA. Such IPN polymer networks are described in U.S. Pat. No. 6,022,902 incorporated by reference herein in its entirety. In this patent, Silon® is described as a breathable, hydrophobic polysiloxane membrane reinforced with poly(tetrafluoroethylene). [0030]
  • The removal of the siloxane from the IPN leaves behind a porous PTFE structure without having to go through the added steps of stretching or expanding the PTFE in order to obtain the porous structure. Quite obviously, this simplifies the manufacturing process by decreasing the number of steps required, and also increases efficiency. Typically, porous PTFE requires the expanding and stretching steps in order to achieve the porous structure. FIG. 7 illustrates generally at [0031] 20 a porous PTFE structure after removal of the siloxane. The removal of the siloxane leaves behind the porous structure wherein voids or pockets of air 25, are found intermeshed in between pockets of PTFE 30.
  • The novel porous PTFE structure produced by the present inventive process is quite different from the porous structure produced by PTFE which has been stretched, or expanded. Typically, PTFE which has been stretched, or ePTFE has a node and fibril structure as seen in FIG. 8. After stretching, the ePTFE possesses [0032] nodes 32 connected to fibrils 34. In between the nodes and fibrils are pores 36.
  • Removing the siloxane from the IPN of siloxane/PTFE through the use of heat involves heating the IPN structure to temperatures of between about 300° C. and about 390° C. Chemical removal of the siloxane may be accomplished using a compound selected from the group consisting of toluene, heptane, chloroform. [0033]
  • Sintering is typically accomplished at or above the crystalline melting point of PTFE. Sintering is synonymous with recrystallization. It refers to the bonding of particles in a mass by molecular (or atomic) attraction in the solid state through the application of heat below the melting point of the polymer. Sintering causes the strengthening of the powder mass and normally results in densification and often recrystallization. [0034]
  • A PTFE tube may be extruded as a tube from an extrusion device, or extruded as a film and subsequently wrapped into a tube. Extrusion techniques of PTFE are well known in the art. [0035]
  • As discussed above, the stent may be covered on the interior surface [0036] 11 of the stent 10, the exterior surface 13 of the stent 10, or both. Preferably, the stent 10 is covered on both the interior 11 and the exterior 13 surfaces of the stent 10. Having the entire surface of the stent 10 covered with the porous PTFE of the present invention provides an effective barrier about the stent 10 preventing excessive cell or tissue growth, or thrombus formation through the expanded wall of a tubular stent 10.
  • In order for the covering of porous PTFE to function effectively in combination with an expandable stent, the material must exhibit sufficient expansion characteristics so as to enable the stent cover to expand along with the radial expansion of the [0037] stent 10. If the covering material does not effectively expand with the stent, several problems can arise. The covering material may tear, and may even detach from the surface of the stent if improper or dissimilar expansion of the covering material occurs with the expansion of the stent.
  • In order to improve the adhesion, and further prevent detachment of the PTFE covering from the stent, the PTFE may be fused or welded around or to the metal stent. This may be accomplished either through a heating process and/or bonding process. If heating is utilized, typically the PTFE will be heated above its sintering temperature. [0038]
  • If an adhesive is utilized, preferably a biocompatible adhesive is used. Such adhesives are known to one of skill in the art and include, for example, polyurethanes, epoxies, cyanoacrylates, polyamides, polyimides, silicones, and so forth. Dispersions of PTFE or FEP (fluoroethylpropylene) may also be utilized. This list is not exclusive and is intended for illustrative purposes only, and is in no way intended as a limitation on the scope of the present invention. There is a vast number of adhesives that can be used for such applications, limited by their biocompatibility, and by their ability to bond to polymeric materials (e.g. PTFE) and metals, particularly in aqueous environments. [0039]
  • The covering material may also be assembled to the intraluminal device in more than one piece. Such a combination would require overlapping of sorts of the PTFE material, and subsequent fusion or adhesive bonding of the porous PTFE material to itself. [0040]
  • It is preferable, however, to utilize the porous PTFE covering in a continuous form such as a membrane or thin film. The porous PTFE (after removal of the siloxane), in the form of a membrane or a thin film, thus, preferably completely wraps the metal stent, thereby providing a barrier that physically isolates the stent from surrounding blood and tissue. This barrier further helps prevent healing or diseased layers of tissue from directly contacting the stent, or from passing through the stent in any way. The porous PTFE allows the passage of fluids and vital materials, however, while still serving as a barrier to tissue growth. [0041]

Claims (13)

1. An endoprosthesis device comprising:
an elongate radially expandable tubular stent having an interior surface and an exterior surface extending along a longitudinal stent axis; and
a stent cover on said interior surface, exterior surface or both, said stent cover being formed of a polytetrafluoroethylene having no node and fibril structure;
wherein said porous polytetrafluoroethylene is formed by the steps of:
providing an interpenetrating network of siloxane/polytetrafluoroethylene;
removing said siloxane from said interpenetrating network leaving a porous polytetrafluoroethylene structure without a node and fibril structure.
2. The endoprosthesis device of claim 1 wherein said stent cover is on said exterior surface and said interior surface of said stent.
3. The endoprosthesis device of claim 1 wherein said stent cover is expandable upon expansion of said stent.
4. The endoprosthesis device of claim 1 wherein said siloxane is chemically extracted from said siloxane/polytetrafluoroethylene interpenetrating network.
5. The endoprosthesis device of claim 4 wherein said siloxane is chemically extracted by a compound selected from the group consisting of toluene, heptane and chloroform.
6. The endoprosthesis device of claim 1 wherein said siloxane is removed from said siloxane/polytetrafluoroethylene interpenetrating network by heating said network to a temperature of at least about 300° C.
7-12 (canceled).
13. An endoprosthesis device comprising:
an elongate radially expandable tubular stent having an interior surface and an exterior surface extending along a longitudinal stent axis; and
a stent cover on said interior surface, exterior surface or both, which is formed of a polytetrafluoroethylene having no node and fibril structure;
wherein said porous polytetrafluoroethylene comprises a porous structure—having voids intermeshed between pockets of PTFE without a node and fibril structure.
14 (canceled).
15. The endoprosthesis device of claim 13 wherein said stent cover is on said exterior surface and said interior surface of said stent.
16. The endoprosthesis device of claim 13 wherein said stent cover is expandable upon expansion of said stent.
17. The endoprosthesis device of claim 1 wherein said siloxane is polydimethylsiloxane.
18. The method of claim 7 wherein said siloxane is polydimethylsiloxane.
US10/858,589 2000-11-02 2004-06-02 Stent covering formed of porous polytetraflouroethylene Abandoned US20040220659A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/858,589 US20040220659A1 (en) 2000-11-02 2004-06-02 Stent covering formed of porous polytetraflouroethylene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/704,494 US6770086B1 (en) 2000-11-02 2000-11-02 Stent covering formed of porous polytetraflouroethylene
US10/858,589 US20040220659A1 (en) 2000-11-02 2004-06-02 Stent covering formed of porous polytetraflouroethylene

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/704,494 Continuation US6770086B1 (en) 2000-11-02 2000-11-02 Stent covering formed of porous polytetraflouroethylene

Publications (1)

Publication Number Publication Date
US20040220659A1 true US20040220659A1 (en) 2004-11-04

Family

ID=24829763

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/704,494 Expired - Lifetime US6770086B1 (en) 2000-11-02 2000-11-02 Stent covering formed of porous polytetraflouroethylene
US10/002,521 Abandoned US20020111667A1 (en) 2000-11-02 2001-11-01 Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture
US10/858,589 Abandoned US20040220659A1 (en) 2000-11-02 2004-06-02 Stent covering formed of porous polytetraflouroethylene

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/704,494 Expired - Lifetime US6770086B1 (en) 2000-11-02 2000-11-02 Stent covering formed of porous polytetraflouroethylene
US10/002,521 Abandoned US20020111667A1 (en) 2000-11-02 2001-11-01 Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture

Country Status (7)

Country Link
US (3) US6770086B1 (en)
EP (2) EP1385691B1 (en)
JP (1) JP3853734B2 (en)
AT (1) ATE485936T1 (en)
AU (1) AU2002225830A1 (en)
DE (1) DE60143364D1 (en)
WO (1) WO2002036332A2 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111667A1 (en) * 2000-11-02 2002-08-15 Scimed Life Systems, Inc. Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture
US7955382B2 (en) 2006-09-15 2011-06-07 Boston Scientific Scimed, Inc. Endoprosthesis with adjustable surface features
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8002821B2 (en) 2006-09-18 2011-08-23 Boston Scientific Scimed, Inc. Bioerodible metallic ENDOPROSTHESES
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8052744B2 (en) 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8052743B2 (en) 2006-08-02 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
US8057534B2 (en) 2006-09-15 2011-11-15 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8080055B2 (en) 2006-12-28 2011-12-20 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US8128689B2 (en) 2006-09-15 2012-03-06 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis with biostable inorganic layers
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8267992B2 (en) 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8303643B2 (en) 2001-06-27 2012-11-06 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US8808726B2 (en) 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579314B1 (en) * 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
US6264684B1 (en) 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
US6451047B2 (en) 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6656215B1 (en) * 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6776604B1 (en) * 2001-12-20 2004-08-17 Trivascular, Inc. Method and apparatus for shape forming endovascular graft material
US7090693B1 (en) 2001-12-20 2006-08-15 Boston Scientific Santa Rosa Corp. Endovascular graft joint and method for manufacture
US7125464B2 (en) 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US20040093056A1 (en) 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
AU2003290675A1 (en) * 2002-11-07 2004-06-03 Abbott Laboratories Method of loading beneficial agent to a prosthesis by fluid-jet application
US20060121080A1 (en) * 2002-11-13 2006-06-08 Lye Whye K Medical devices having nanoporous layers and methods for making the same
JP2006514848A (en) * 2002-11-13 2006-05-18 セタゴン インコーポレーティッド Medical device having porous layer and method for producing the same
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
US8435285B2 (en) 2003-11-25 2013-05-07 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
US20050113904A1 (en) * 2003-11-25 2005-05-26 Shank Peter J. Composite stent with inner and outer stent elements and method of using the same
US7195644B2 (en) * 2004-03-02 2007-03-27 Joint Synergy, Llc Ball and dual socket joint
WO2006034114A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film devices for occlusion of a vessel
US20060079954A1 (en) * 2004-10-08 2006-04-13 Robert Burgermeister Geometry and material for high strength, high flexibility, controlled recoil stent
CN101065424B (en) 2004-11-24 2011-09-14 唐纳森公司 Ptfe membrane
US20080140172A1 (en) * 2004-12-13 2008-06-12 Robert Hunt Carpenter Multi-Wall Expandable Device Capable Of Drug Delivery Related Applications
US20060149366A1 (en) * 2004-12-31 2006-07-06 Jamie Henderson Sintered structures for vascular graft
US7524445B2 (en) * 2004-12-31 2009-04-28 Boston Scientific Scimed, Inc. Method for making ePTFE and structure containing such ePTFE, such as a vascular graft
US7857843B2 (en) * 2004-12-31 2010-12-28 Boston Scientific Scimed, Inc. Differentially expanded vascular graft
US7806922B2 (en) * 2004-12-31 2010-10-05 Boston Scientific Scimed, Inc. Sintered ring supported vascular graft
US8535702B2 (en) 2005-02-01 2013-09-17 Boston Scientific Scimed, Inc. Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
US7789888B2 (en) * 2005-02-14 2010-09-07 Bartee Chad M PTFE composite multi-layer material
US20060233990A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
US20060233991A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
US8163002B2 (en) * 2005-11-14 2012-04-24 Vascular Devices Llc Self-sealing vascular graft
US7867176B2 (en) * 2005-12-27 2011-01-11 Cordis Corporation Variable stiffness guidewire
US20070203564A1 (en) * 2006-02-28 2007-08-30 Boston Scientific Scimed, Inc. Biodegradable implants having accelerated biodegradation properties in vivo
US8025693B2 (en) * 2006-03-01 2011-09-27 Boston Scientific Scimed, Inc. Stent-graft having flexible geometries and methods of producing the same
US7785317B2 (en) 2006-03-29 2010-08-31 Codman & Shurtleff, Inc. Joined metal tubing and method of manufacture
US7666496B2 (en) 2006-05-24 2010-02-23 Boston Scientific Scimed, Inc. Micro-sintered node ePTFE structure
US7766935B2 (en) 2006-06-12 2010-08-03 Codman & Shurtleff, Inc. Modified headpiece for hydraulic coil deployment system
US7670353B2 (en) * 2006-06-12 2010-03-02 Codman & Shurtleff, Inc. Modified headpiece for hydraulic coil deployment system
US8585732B2 (en) * 2006-06-14 2013-11-19 DePuy Synthes Products, LLC Retrieval device with sidewall grippers
EP2073765A2 (en) * 2006-09-25 2009-07-01 Boston Scientific Limited Injection of therapeutic into porous regions of a medical device
JP5037087B2 (en) * 2006-10-31 2012-09-26 日本バルカー工業株式会社 Method for forming porous PTFE layer, and porous PTFE layer and molded article obtained by this forming method
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
WO2009046372A2 (en) 2007-10-04 2009-04-09 Trivascular2, Inc. Modular vascular graft for low profile percutaneous delivery
US8142490B2 (en) 2007-10-24 2012-03-27 Cordis Corporation Stent segments axially connected by thin film
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8196279B2 (en) 2008-02-27 2012-06-12 C. R. Bard, Inc. Stent-graft covering process
US8252048B2 (en) * 2008-03-19 2012-08-28 Boston Scientific Scimed, Inc. Drug eluting stent and method of making the same
US8257640B2 (en) 2009-08-07 2012-09-04 Zeus Industrial Products, Inc. Multilayered composite structure with electrospun layer
US20130268062A1 (en) 2012-04-05 2013-10-10 Zeus Industrial Products, Inc. Composite prosthetic devices
EP2445444B1 (en) 2009-06-23 2018-09-26 Endospan Ltd. Vascular prostheses for treating aneurysms
CA2767596C (en) 2009-07-09 2015-11-24 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
EP2533722B1 (en) 2010-02-08 2017-03-29 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US20110208289A1 (en) * 2010-02-25 2011-08-25 Endospan Ltd. Flexible Stent-Grafts
JP5661334B2 (en) * 2010-05-26 2015-01-28 テルモ株式会社 Stent
US8389041B2 (en) 2010-06-17 2013-03-05 Abbott Cardiovascular Systems, Inc. Systems and methods for rotating and coating an implantable device
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US8808848B2 (en) 2010-09-10 2014-08-19 W. L. Gore & Associates, Inc. Porous article
CA2826022A1 (en) * 2011-02-03 2012-08-09 Endospan Ltd. Implantable medical devices constructed of shape memory material
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
US9839510B2 (en) 2011-08-28 2017-12-12 Endospan Ltd. Stent-grafts with post-deployment variable radial displacement
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
EP2785277B1 (en) 2011-12-04 2017-04-05 Endospan Ltd. Branched stent-graft system
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
EP2956180B1 (en) 2013-02-15 2018-08-01 Boston Scientific Scimed, Inc. Bioerodible magnesium alloy microstructures for endoprostheses
JP2017501756A (en) 2013-10-29 2017-01-19 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Bioerodible magnesium alloy microstructure for internal prostheses
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
WO2016048985A1 (en) * 2014-09-23 2016-03-31 Boston Scientific Scimed, Inc. Implantable medical device with shape memory polymer filter layer
US10485684B2 (en) 2014-12-18 2019-11-26 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
CA2973155A1 (en) 2015-03-11 2016-09-15 Boston Scientific Scimed, Inc. Bioerodible magnesium alloy microstructures for endoprostheses
CN105802192A (en) * 2016-04-29 2016-07-27 苏州林华医疗器械股份有限公司 Novel material applied to indwelling needle catheter and preparation method thereof
US20210221961A1 (en) * 2020-01-16 2021-07-22 Wisconsin Alumni Research Foundation Methods of making polytetrafluoroethylene/polymer composites and uses thereof
US20220211477A1 (en) * 2021-01-06 2022-07-07 Medtronic Inc. Surgical system and methods of use

Citations (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1978A (en) * 1841-02-13 Manner of constructing- stoves
US3407249A (en) * 1966-01-25 1968-10-22 American Cyanamid Co Porous, extensively fibrillated polytetrafluoroethylene and method of preparing same
US4196070A (en) * 1977-12-12 1980-04-01 Nuclepore Corporation Method for forming microporous fluorocarbon polymer sheet and product
US4289600A (en) * 1978-03-31 1981-09-15 Hooker Chemicals & Plastics Corp. Microporous membrane materials
US4304010A (en) * 1978-10-12 1981-12-08 Sumitomo Electric Industries, Ltd. Tubular polytetrafluoroethylene prosthesis with porous elastomer coating
US4321711A (en) * 1978-10-18 1982-03-30 Sumitomo Electric Industries, Ltd. Vascular prosthesis
US4533369A (en) * 1982-05-28 1985-08-06 Sumitomo Electric Industries, Ltd. Gas-permselective composite membranes and process for the production thereof
US4576608A (en) * 1980-11-06 1986-03-18 Homsy Charles A Porous body-implantable polytetrafluoroethylene
US4605406A (en) * 1984-08-03 1986-08-12 Medtronic, Inc. Method for fabricating prosthesis material
US4657544A (en) * 1984-04-18 1987-04-14 Cordis Corporation Cardiovascular graft and method of forming same
US4725273A (en) * 1985-08-23 1988-02-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel having excellent patency
US4764560A (en) * 1985-11-13 1988-08-16 General Electric Company Interpenetrating polymeric network comprising polytetrafluoroethylene and polysiloxane
US4822361A (en) * 1985-12-24 1989-04-18 Sumitomo Electric Industries, Ltd. Tubular prosthesis having a composite structure
US4828772A (en) * 1984-10-09 1989-05-09 Millipore Corporation Microporous membranes of ultrahigh molecular weight polyethylene
US4834746A (en) * 1983-06-06 1989-05-30 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel and process for preparing the same
US4849285A (en) * 1987-06-01 1989-07-18 Bio Med Sciences, Inc. Composite macrostructure of ceramic and organic biomaterials
US4863604A (en) * 1987-02-05 1989-09-05 Parker-Hannifin Corporation Microporous asymmetric polyfluorocarbon membranes
US4874568A (en) * 1988-09-26 1989-10-17 The Dow Chemical Company Process of making a porous membrane
US4906377A (en) * 1988-05-04 1990-03-06 Millipore Corporation Fluorocarbon membranes and process for making fluorocarbon membranes
US4945125A (en) * 1987-01-05 1990-07-31 Tetratec Corporation Process of producing a fibrillated semi-interpenetrating polymer network of polytetrafluoroethylene and silicone elastomer and shaped products thereof
US4951381A (en) * 1988-10-03 1990-08-28 Alps Electric Co., Ltd. Method of manufacturing a magnetic head slider
US4963304A (en) * 1988-09-26 1990-10-16 The Dow Chemical Company Process for preparing microporous membranes
US4986832A (en) * 1987-09-04 1991-01-22 Ube Industries, Ltd. Artificial blood vessel and process for preparing it
US4997603A (en) * 1988-08-05 1991-03-05 Hoechst Celanese Corp. Process for formation of halogenated polymeric microporous membranes having improved strength properties
US5066683A (en) * 1987-01-05 1991-11-19 Tetratec Corporation Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof
US5098625A (en) * 1989-03-14 1992-03-24 Yeu Ming Tai Chemical Industrial Co., Ltd. Process for forming an expanded porous tetrafluoroethylene polymer
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5141522A (en) * 1990-02-06 1992-08-25 American Cyanamid Company Composite material having absorbable and non-absorbable components for use with mammalian tissue
US5157058A (en) * 1987-01-05 1992-10-20 Tetratec Corporation Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof
US5198162A (en) * 1984-12-19 1993-03-30 Scimat Limited Microporous films
US5248428A (en) * 1991-06-28 1993-09-28 Minnesota Mining And Manufacturing Company Article for separations and purifications and method of controlling porosity therein
US5433909A (en) * 1992-03-13 1995-07-18 Atrium Medical Corporation Method of making controlled porosity expanded polytetrafluoroethylene products
US5466509A (en) * 1993-01-15 1995-11-14 Impra, Inc. Textured, porous, expanded PTFE
US5474128A (en) * 1993-07-02 1995-12-12 Best Tool Co., Inc. Telescoping conduits for increasing the fluid resistance of well production tubing inadvertently dropped in an oil or gas well
US5607464A (en) * 1991-02-28 1997-03-04 Medtronic, Inc. Prosthetic vascular graft with a pleated structure
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5641373A (en) * 1995-04-17 1997-06-24 Baxter International Inc. Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US5693085A (en) * 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5700285A (en) * 1993-08-18 1997-12-23 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5716660A (en) * 1994-08-12 1998-02-10 Meadox Medicals, Inc. Tubular polytetrafluoroethylene implantable prostheses
US5723526A (en) * 1993-09-08 1998-03-03 Teijin Chemicals Ltd Resin composition and molded article
US5741326A (en) * 1996-07-15 1998-04-21 Cordis Corporation Low profile thermally set wrapped cover for a percutaneously deployed stent
US5744515A (en) * 1995-05-26 1998-04-28 Bsi Corporation Method and implantable article for promoting endothelialization
US5749880A (en) * 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5769884A (en) * 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US5776185A (en) * 1994-09-27 1998-07-07 Alessandro Verona Cardiovascular graft
US5782904A (en) * 1993-09-30 1998-07-21 Endogad Research Pty Limited Intraluminal graft
US5788626A (en) * 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US5824046A (en) * 1996-09-27 1998-10-20 Scimed Life Systems, Inc. Covered stent
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US5840775A (en) * 1992-06-25 1998-11-24 E. I. Du Pont De Nemours And Company Porous polytetraflouroethylene and preparation
US5843161A (en) * 1996-06-26 1998-12-01 Cordis Corporation Endoprosthesis assembly for percutaneous deployment and method of deploying same
US5925074A (en) * 1996-12-03 1999-07-20 Atrium Medical Corporation Vascular endoprosthesis and method
US5928280A (en) * 1995-09-11 1999-07-27 William Cook Europe A/S Expandable endovascular stent
US5928279A (en) * 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
US5980923A (en) * 1994-02-23 1999-11-09 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
US6004348A (en) * 1995-03-10 1999-12-21 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US6015609A (en) * 1996-04-04 2000-01-18 Navartis Ag Process for manufacture of a porous polymer from a mixture
US6022902A (en) * 1989-10-31 2000-02-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Porous article with surface functionality and method for preparing same
US6053943A (en) * 1995-12-08 2000-04-25 Impra, Inc. Endoluminal graft with integral structural support and method for making same
US6060530A (en) * 1996-04-04 2000-05-09 Novartis Ag Process for manufacture of a porous polymer by use of a porogen
US6143675A (en) * 1995-06-07 2000-11-07 W. L. Gore & Associates (Uk) Ltd. Porous composite
US6156064A (en) * 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
US6190590B1 (en) * 1996-02-28 2001-02-20 Impra, Inc. Apparatus and method for making flanged graft for end-to-side anastomosis
US6235377B1 (en) * 1995-09-05 2001-05-22 Bio Med Sciences, Inc. Microporous membrane with a stratified pore structure created in situ and process
US6245099B1 (en) * 1998-09-30 2001-06-12 Impra, Inc. Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device
US6293969B1 (en) * 1997-01-29 2001-09-25 Endovascular Technologies, Inc. Bell-bottom modular stent-graft
US6361559B1 (en) * 1998-06-10 2002-03-26 Converge Medical, Inc. Thermal securing anastomosis systems
US20020111667A1 (en) * 2000-11-02 2002-08-15 Scimed Life Systems, Inc. Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture
US6540780B1 (en) * 1998-11-23 2003-04-01 Medtronic, Inc. Porous synthetic vascular grafts with oriented ingrowth channels
US6702965B2 (en) * 1997-02-06 2004-03-09 Bollore Method of forming a porous composite product, in particular with a high specific surface
US6770202B1 (en) * 1999-04-14 2004-08-03 Pall Corporation Porous membrane
US7083640B2 (en) * 1995-03-10 2006-08-01 C. R. Bard, Inc. Covered stent with encapsulated ends

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283492C (en) 1985-11-13 1991-04-23 Tyrone D. Mitchell Interpenetrating polymeric networks comprising polytetrafluoroethylene and polysiloxane
JP3077859B2 (en) * 1992-10-02 2000-08-21 田中貴金属工業株式会社 Method for removing surfactant from material sheet for gas diffusion electrode
DE69534230T2 (en) 1994-06-27 2006-01-19 Bard Peripheral Vascular, Inc., Tempe RADIAL EXPANDABLE POLYTETRAFLUOROETHYLENE AND EXPANDABLE ENDOVASCULAR STENTS SHAPED THEREFROM
US5747128A (en) 1996-01-29 1998-05-05 W. L. Gore & Associates, Inc. Radially supported polytetrafluoroethylene vascular graft
WO1998026731A2 (en) * 1996-12-03 1998-06-25 Atrium Medical Corporation Multi-stage prosthesis
US6139573A (en) 1997-03-05 2000-10-31 Scimed Life Systems, Inc. Conformal laminate stent device
US6203536B1 (en) * 1997-06-17 2001-03-20 Medtronic, Inc. Medical device for delivering a therapeutic substance and method therefor
USH1978H1 (en) * 1999-05-14 2001-08-07 Kimberly-Clark Worldwide, Inc. Monolithic films having zoned breathability

Patent Citations (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1978A (en) * 1841-02-13 Manner of constructing- stoves
US3407249A (en) * 1966-01-25 1968-10-22 American Cyanamid Co Porous, extensively fibrillated polytetrafluoroethylene and method of preparing same
US4196070A (en) * 1977-12-12 1980-04-01 Nuclepore Corporation Method for forming microporous fluorocarbon polymer sheet and product
US4289600A (en) * 1978-03-31 1981-09-15 Hooker Chemicals & Plastics Corp. Microporous membrane materials
US4304010A (en) * 1978-10-12 1981-12-08 Sumitomo Electric Industries, Ltd. Tubular polytetrafluoroethylene prosthesis with porous elastomer coating
US4321711A (en) * 1978-10-18 1982-03-30 Sumitomo Electric Industries, Ltd. Vascular prosthesis
US4576608A (en) * 1980-11-06 1986-03-18 Homsy Charles A Porous body-implantable polytetrafluoroethylene
US4533369A (en) * 1982-05-28 1985-08-06 Sumitomo Electric Industries, Ltd. Gas-permselective composite membranes and process for the production thereof
US4834746A (en) * 1983-06-06 1989-05-30 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel and process for preparing the same
US4657544A (en) * 1984-04-18 1987-04-14 Cordis Corporation Cardiovascular graft and method of forming same
US4605406A (en) * 1984-08-03 1986-08-12 Medtronic, Inc. Method for fabricating prosthesis material
US4828772A (en) * 1984-10-09 1989-05-09 Millipore Corporation Microporous membranes of ultrahigh molecular weight polyethylene
US5198162A (en) * 1984-12-19 1993-03-30 Scimat Limited Microporous films
US4725273A (en) * 1985-08-23 1988-02-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel having excellent patency
US4764560A (en) * 1985-11-13 1988-08-16 General Electric Company Interpenetrating polymeric network comprising polytetrafluoroethylene and polysiloxane
US4822361A (en) * 1985-12-24 1989-04-18 Sumitomo Electric Industries, Ltd. Tubular prosthesis having a composite structure
US5066683A (en) * 1987-01-05 1991-11-19 Tetratec Corporation Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof
US4945125A (en) * 1987-01-05 1990-07-31 Tetratec Corporation Process of producing a fibrillated semi-interpenetrating polymer network of polytetrafluoroethylene and silicone elastomer and shaped products thereof
US5157058A (en) * 1987-01-05 1992-10-20 Tetratec Corporation Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof
US4863604A (en) * 1987-02-05 1989-09-05 Parker-Hannifin Corporation Microporous asymmetric polyfluorocarbon membranes
US4849285A (en) * 1987-06-01 1989-07-18 Bio Med Sciences, Inc. Composite macrostructure of ceramic and organic biomaterials
US4986832A (en) * 1987-09-04 1991-01-22 Ube Industries, Ltd. Artificial blood vessel and process for preparing it
US4906377A (en) * 1988-05-04 1990-03-06 Millipore Corporation Fluorocarbon membranes and process for making fluorocarbon membranes
US4997603A (en) * 1988-08-05 1991-03-05 Hoechst Celanese Corp. Process for formation of halogenated polymeric microporous membranes having improved strength properties
US4963304A (en) * 1988-09-26 1990-10-16 The Dow Chemical Company Process for preparing microporous membranes
US4874568A (en) * 1988-09-26 1989-10-17 The Dow Chemical Company Process of making a porous membrane
US4951381A (en) * 1988-10-03 1990-08-28 Alps Electric Co., Ltd. Method of manufacturing a magnetic head slider
US5098625A (en) * 1989-03-14 1992-03-24 Yeu Ming Tai Chemical Industrial Co., Ltd. Process for forming an expanded porous tetrafluoroethylene polymer
US6022902A (en) * 1989-10-31 2000-02-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Porous article with surface functionality and method for preparing same
US5141522A (en) * 1990-02-06 1992-08-25 American Cyanamid Company Composite material having absorbable and non-absorbable components for use with mammalian tissue
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5607464A (en) * 1991-02-28 1997-03-04 Medtronic, Inc. Prosthetic vascular graft with a pleated structure
US5248428A (en) * 1991-06-28 1993-09-28 Minnesota Mining And Manufacturing Company Article for separations and purifications and method of controlling porosity therein
US5980799A (en) * 1992-03-13 1999-11-09 Atrium Medical Corporation Methods of making controlled porosity expanded polytetrafluoroethylene products and fabrication
US5474824A (en) * 1992-03-13 1995-12-12 Atrium Medical Corporation Process for expanding polytetrafluoroethylene and products produced thereby
US5861033A (en) * 1992-03-13 1999-01-19 Atrium Medical Corporation Method of making controlled porosity expanded polytetrafluoroethylene products and fabrication
US5433909A (en) * 1992-03-13 1995-07-18 Atrium Medical Corporation Method of making controlled porosity expanded polytetrafluoroethylene products
US5840775A (en) * 1992-06-25 1998-11-24 E. I. Du Pont De Nemours And Company Porous polytetraflouroethylene and preparation
US5466509A (en) * 1993-01-15 1995-11-14 Impra, Inc. Textured, porous, expanded PTFE
US5474128A (en) * 1993-07-02 1995-12-12 Best Tool Co., Inc. Telescoping conduits for increasing the fluid resistance of well production tubing inadvertently dropped in an oil or gas well
US5810870A (en) * 1993-08-18 1998-09-22 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5925075A (en) * 1993-08-18 1999-07-20 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5700285A (en) * 1993-08-18 1997-12-23 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5723526A (en) * 1993-09-08 1998-03-03 Teijin Chemicals Ltd Resin composition and molded article
US5782904A (en) * 1993-09-30 1998-07-21 Endogad Research Pty Limited Intraluminal graft
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5980923A (en) * 1994-02-23 1999-11-09 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
US5693085A (en) * 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5716660A (en) * 1994-08-12 1998-02-10 Meadox Medicals, Inc. Tubular polytetrafluoroethylene implantable prostheses
US5776185A (en) * 1994-09-27 1998-07-07 Alessandro Verona Cardiovascular graft
US7083640B2 (en) * 1995-03-10 2006-08-01 C. R. Bard, Inc. Covered stent with encapsulated ends
US6004348A (en) * 1995-03-10 1999-12-21 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5749880A (en) * 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5641373A (en) * 1995-04-17 1997-06-24 Baxter International Inc. Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US5843173A (en) * 1995-04-17 1998-12-01 Baxter International Inc. Radially-enlargeable PTFE tape-reinforced vascular grafts and their methods of manufacture
US5744515A (en) * 1995-05-26 1998-04-28 Bsi Corporation Method and implantable article for promoting endothelialization
US6143675A (en) * 1995-06-07 2000-11-07 W. L. Gore & Associates (Uk) Ltd. Porous composite
US6235377B1 (en) * 1995-09-05 2001-05-22 Bio Med Sciences, Inc. Microporous membrane with a stratified pore structure created in situ and process
US5928280A (en) * 1995-09-11 1999-07-27 William Cook Europe A/S Expandable endovascular stent
US5788626A (en) * 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US6053943A (en) * 1995-12-08 2000-04-25 Impra, Inc. Endoluminal graft with integral structural support and method for making same
US6190590B1 (en) * 1996-02-28 2001-02-20 Impra, Inc. Apparatus and method for making flanged graft for end-to-side anastomosis
US6015609A (en) * 1996-04-04 2000-01-18 Navartis Ag Process for manufacture of a porous polymer from a mixture
US6060530A (en) * 1996-04-04 2000-05-09 Novartis Ag Process for manufacture of a porous polymer by use of a porogen
US5843161A (en) * 1996-06-26 1998-12-01 Cordis Corporation Endoprosthesis assembly for percutaneous deployment and method of deploying same
US5769884A (en) * 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US5928279A (en) * 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
US5741326A (en) * 1996-07-15 1998-04-21 Cordis Corporation Low profile thermally set wrapped cover for a percutaneously deployed stent
US5948191A (en) * 1996-07-15 1999-09-07 Cordis Corporation Low profile, thermally set wrapped cover for a percutaneously deployed stent
US5824046A (en) * 1996-09-27 1998-10-20 Scimed Life Systems, Inc. Covered stent
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US5925074A (en) * 1996-12-03 1999-07-20 Atrium Medical Corporation Vascular endoprosthesis and method
US6293969B1 (en) * 1997-01-29 2001-09-25 Endovascular Technologies, Inc. Bell-bottom modular stent-graft
US6702965B2 (en) * 1997-02-06 2004-03-09 Bollore Method of forming a porous composite product, in particular with a high specific surface
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US6361559B1 (en) * 1998-06-10 2002-03-26 Converge Medical, Inc. Thermal securing anastomosis systems
US6156064A (en) * 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
US6245099B1 (en) * 1998-09-30 2001-06-12 Impra, Inc. Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device
US6540780B1 (en) * 1998-11-23 2003-04-01 Medtronic, Inc. Porous synthetic vascular grafts with oriented ingrowth channels
US6770202B1 (en) * 1999-04-14 2004-08-03 Pall Corporation Porous membrane
US20020111667A1 (en) * 2000-11-02 2002-08-15 Scimed Life Systems, Inc. Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111667A1 (en) * 2000-11-02 2002-08-15 Scimed Life Systems, Inc. Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture
US8303643B2 (en) 2001-06-27 2012-11-06 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8052743B2 (en) 2006-08-02 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
US8052744B2 (en) 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US8057534B2 (en) 2006-09-15 2011-11-15 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8128689B2 (en) 2006-09-15 2012-03-06 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis with biostable inorganic layers
US7955382B2 (en) 2006-09-15 2011-06-07 Boston Scientific Scimed, Inc. Endoprosthesis with adjustable surface features
US8808726B2 (en) 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
US8002821B2 (en) 2006-09-18 2011-08-23 Boston Scientific Scimed, Inc. Bioerodible metallic ENDOPROSTHESES
US8715339B2 (en) 2006-12-28 2014-05-06 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8080055B2 (en) 2006-12-28 2011-12-20 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8267992B2 (en) 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses

Also Published As

Publication number Publication date
EP1385691B1 (en) 2010-10-27
JP3853734B2 (en) 2006-12-06
US20020111667A1 (en) 2002-08-15
EP2275248A1 (en) 2011-01-19
EP1385691A2 (en) 2004-02-04
WO2002036332A2 (en) 2002-05-10
US6770086B1 (en) 2004-08-03
AU2002225830A1 (en) 2002-05-15
WO2002036332A3 (en) 2002-09-12
DE60143364D1 (en) 2010-12-09
JP2004512876A (en) 2004-04-30
ATE485936T1 (en) 2010-11-15

Similar Documents

Publication Publication Date Title
US6770086B1 (en) Stent covering formed of porous polytetraflouroethylene
JP3927545B2 (en) Tubular PTFE graft with radially expandable stent
US6652570B2 (en) Composite vascular graft
EP1041941B1 (en) Supported graft
EP1164972B1 (en) Polymer coated stent
EP0934034B1 (en) Improved covered stent
EP0814729B1 (en) Endoluminal encapsulated stent and methods of manufacture
EP1207815B1 (en) Tubular stent-graft composite device and method of manufacture
US20020111668A1 (en) Seamless braided or spun stent cover
JP2003534027A (en) Intravascular stent device coated with a thin polymer
CA2322639C (en) Improved ptfe vascular prosthesis and method of manufacture
CA2429619C (en) Composite tubular prostheses
EP1767169B1 (en) Tubular stent-graft composite device and method of manufacture

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868

Effective date: 20050101

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION